Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

DATAPHARM A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.9% 1.9% 1.9% 1.9% 1.9% 1.9% 1.9% 1.9%   Bankruptcy risk   5.5% 15.9% 6.8% 2.1% 9.8% 11.9% 8.3% 8.1%   Credit score (0-100)   43 13 35 67 24 19 30 30   Credit rating   BBB BB BBB A BB BB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,233 841 671 921 1,143 890 0.0 0.0   EBITDA   861 438 411 661 858 584 0.0 0.0   EBIT   -3,333 -3,406 411 661 858 584 0.0 0.0   Pre-tax profit (PTP)   -3,186.2 -3,273.2 390.4 771.8 1,078.3 963.2 0.0 0.0   Net earnings   -2,485.4 -2,553.0 304.9 602.1 840.9 703.7 0.0 0.0   Pre-tax profit without non-rec. items   -3,186 -3,273 390 772 1,078 963 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   10,544 7,991 8,296 8,898 9,739 10,442 5,739 5,739   Interest-bearing liabilities   0.0 0.0 1,100 0.8 0.8 0.0 0.0 0.0   Balance sheet total (assets)   12,474 16,944 11,261 10,172 10,972 13,570 5,739 5,739   Net Debt   0.0 0.0 1,100 0.8 -37.7 0.0 -5,739 -5,739     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,233 841 671 921 1,143 890 0.0 0.0   Gross profit growth   -0.6% -31.8% -20.2% 37.2% 24.1% -22.1% -100.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   12,474 16,944 11,261 10,172 10,972 13,570 5,739 5,739   Balance sheet change%   -22.6% 35.8% -33.5% -9.7% 7.9% 23.7% -57.7% 0.0%   Added value   861.0 438.5 411.4 661.4 858.0 584.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -8,387 -7,688 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -3.0 -4.0 1.0 2.0 3.0 4.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -270.3% -404.8% 61.3% 71.8% 75.0% 65.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -22.3% -22.2% 3.7% 7.2% 10.2% 7.8% 0.0% 0.0%   ROI %   -24.3% -33.8% 5.9% 8.5% 11.6% 9.5% 0.0% 0.0%   ROE %   -21.1% -27.5% 3.7% 7.0% 9.0% 7.0% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   84.5% 47.2% 73.7% 87.5% 88.8% 76.9% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   0.0% 0.0% 267.3% 0.1% -4.4% 0.0% 0.0% 0.0%   Gearing %   0.0% 0.0% 13.3% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   2.8% 0.0% 22.9% 0.4% 53.6% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   7.9 1.9 3.8 7.0 8.9 4.3 0.0 0.0   Current Ratio   7.9 1.9 3.8 7.0 8.9 4.3 0.0 0.0   Cash and cash equivalent   0.0 0.0 0.0 0.0 38.5 0.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   7,538.6 7,990.7 8,295.6 7,649.4 9,738.5 10,442.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0